Acura Pharmaceuticals reported -282000 in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acelrx Pharmaceuticals ACRX:US $ -8.57M 0.86M
Acura Pharmaceuticals ACUR:US -282000 154K
Intra Cellular Therapies ITCI:US $ -72.49M 13.37M
Johnson & Johnson JNJ:US $ 9309M 1549M
Nektar Therapeutics NKTR:US $ -111.36M 1.88M
Pfizer PFE:US $ 11182M 4046M
Rigel Pharmaceuticals RIGL:US $ -26.02M 8.53M
Shionogi 4507:JP Y 54212M 32274M
Sun Pharmaceuticals SUNP:IN IR 21793.5M 4375.7M
Teva Pharmaceutical TEVA:IT 1.11B 176M
Xeris Pharmaceuticals Inc XERS:US $ -16042000 29.13M